NCT00446420

Brief Summary

Our hypothesis is that adding midazolam and/or fentanyl to propofol sedation for elective outpatient colonoscopy increases cognitive impairment at hospital discharge without improving intraoperative conditions or reducing intraoperative side-effects. 200 healthy patients aged 18 years or older will be randomised to receive propofol or propofol plus midazolam and/or fentanyl. Cognitive impairment will be tested at hospital discharge using Cogstate computerised testing software.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Feb 2007

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2007

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 8, 2007

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 12, 2007

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2008

Completed
Last Updated

May 30, 2013

Status Verified

May 1, 2013

Enrollment Period

1 year

First QC Date

March 8, 2007

Last Update Submit

May 28, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cognitive impairment at hospital discharge after elective outpatient colonoscopy

    Before discharge from daycare facility

Secondary Outcomes (1)

  • Dreaming during sedation, intraoperative operating conditions and complications, satisfaction with care

    Before discharge from daycare facility

Study Arms (2)

1

ACTIVE COMPARATOR

These patients will only receive intravenous propofol which will be titrated to an OAA/S score of 3. They will not receive fentanyl, midazolam or any other drugs

Drug: Propofol, midazolam, fentanyl

2

ACTIVE COMPARATOR

These patients will receive propofol plus midazolam and/or fentanyl. Midazolam and fentanyl will be given in fixed doses first and propofol will be titrated to effect. All drugs will be given intravenously.

Drug: Propofol, midazolam, fentanyl

Interventions

All drugs administered in doses according to anaesthetists' discretion during sedation for colonoscopy

Also known as: Diprivan, Sublimase, Versed
12

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or older presenting for elective outpatient colonoscopy following full bowel preparation

You may not qualify if:

  • No cognitive impairment
  • Adequate English language comprehension
  • Not combined with other procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Melbourne Hospital

Parkville, Victoria, 3050, Australia

Location

Related Publications (1)

  • Padmanabhan U, Leslie K, Eer AS, Maruff P, Silbert BS. Early cognitive impairment after sedation for colonoscopy: the effect of adding midazolam and/or fentanyl to propofol. Anesth Analg. 2009 Nov;109(5):1448-55. doi: 10.1213/ane.0b013e3181a6ad31. Epub 2009 Jul 17.

MeSH Terms

Conditions

Cognitive Dysfunction

Interventions

PropofolMidazolamFentanyl

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsBenzodiazepinesBenzazepinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsPiperidinesHeterocyclic Compounds, 1-Ring

Study Officials

  • Kate Leslie, MD

    Melbourne Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 8, 2007

First Posted

March 12, 2007

Study Start

February 1, 2007

Primary Completion

February 1, 2008

Study Completion

February 1, 2008

Last Updated

May 30, 2013

Record last verified: 2013-05

Locations